正木 克宜

Medicine & Life Sciences

1. 1-Acylglycerophosphocholine O-Acyltransferase 26%
2. 17,18-epoxy-5,8,11,14-eicosatetraenoic acid 33%
3. Adrenal Cortex Hormones 25%
4. Advisory Committees 50%
5. Anaphylaxis 19%
6. Annular Erythema 27%
7. Asthma 100%
8. benralizumab 28%
9. Carbon Monoxide 31%
10. Chronic Obstructive Pulmonary Disease 26%
11. Cohort Studies 21%
12. Coronavirus 65%
13. Dermatophagoides farinae 23%
14. dupilumab 26%
15. Dyspnea 25%
16. Eosinophils 36%
17. Flour 20%
18. Genes 25%
19. Herpesviridae Infections 19%
20. Infections 24%
21. Inflammation 49%
22. Influenza B virus 21%
23. Interleukin-23 39%
24. Interleukin-33 24%
25. Japan 96%
26. Lung 26%
27. Lung Neoplasms 24%
28. Mites 19%
29. Mycobacterium avium 21%
30. Mycobacterium Infections 20%
31. Neutralizing Antibodies 21%
32. Omalizumab 22%
33. Periodontal Index 19%
34. Pneumonia 33%
35. Pulmonary Emphysema 20%
36. Pulmonary Eosinophilia 22%
37. Randomized Controlled Trials 23%
38. resiquimod 25%
39. SARS Virus 56%
40. Serum 28%
41. Severe Acute Respiratory Syndrome 20%
42. Smartphone 56%
43. Smoking Cessation 46%
44. Taste Disorders 24%
45. thymic stromal lymphopoietin 23%
46. Tiotropium Bromide 23%
47. Tobacco Use Disorder 28%
48. Toll-Like Receptor 7 22%
49. Viral Load 19%
50. Withholding Treatment 22%